![]() |
|
|
2
Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX 75390-9073, and Departments of
*
Pathology and
Internal Medicine, UC Davis Medical Center, Sacramento, CA 95817
2To whom correspondence should be addressed. E-mail: ishwarlal.jialal{at}ucdmc.ucdavis.edu.
Flavonoids and related polyphenolics with antioxidant and anti-inflammatory activities may play a role in the prevention of cardiovascular disease by decreasing oxidative stress and inflammation. We wished to determine the effects of cocoa extract supplementation on markers of oxidative stress and inflammation. Healthy subjects (n = 25) were studied at baseline, after cocoa supplementation (36.9 g of dark chocolate bar and 30.95 g of cocoa powder drink) for 6 wk and after a 6-wk washout period. Fasting blood and early morning urine were collected at the three time points. Two indices of flavonoid intake, total phenols and oxygen radical absorbance capacity of plasma, were measured after an overnight fast. Neither was affected by supplementation. Measures of oxidative stress included copper-catalyzed LDL oxidation kinetics and urinary F2 isoprostanes. LDL oxidizability was lower after chocolate supplementation as evidenced by a longer lag time (P < 0.05) of conjugated diene formation (101.0 ± 20.7 min) compared with baseline (91.3 ± 18.0 min) and washout (96.4 ± 7.5 min) phases. There was no effect of chocolate on urinary F2 isoprostane levels or on markers of inflammation including the whole-blood cytokines, interleukin-1 ß, interleukin-6 and tumor necrosis factor-
, high sensitivity C-reactive protein and P-selectin. In conclusion, cocoa products supplementation in humans affects LDL oxidizability, but not urinary F2 isoprostanes or markers of inflammation.
KEY WORDS: cocoa chocolate flavonoids oxidation inflammation humans
This article has been cited by other articles:
![]() |
W D. Crews Jr, D. W Harrison, and J. W Wright A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults Am. J. Clinical Nutrition, April 1, 2008; 87(4): 872 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. K. Chun, S.-J. Chung, K. J. Claycombe, and W. O. Song Serum C-Reactive Protein Concentrations Are Inversely Associated with Dietary Flavonoid Intake in U.S. Adults J. Nutr., April 1, 2008; 138(4): 753 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Devaraj, G. O'Keefe, and I. Jialal Defining the Proinflammatory Phenotype Using High Sensitive C-Reactive Protein Levels as the Biomarker J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4549 - 4554. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Grassi, S. Necozione, C. Lippi, G. Croce, L. Valeri, P. Pasqualetti, G. Desideri, J. B. Blumberg, and C. Ferri Cocoa Reduces Blood Pressure and Insulin Resistance and Improves Endothelium-Dependent Vasodilation in Hypertensives Hypertension, August 1, 2005; 46(2): 398 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sies, T. Schewe, C. Heiss, and M. Kelm Cocoa polyphenols and inflammatory mediators Am. J. Clinical Nutrition, January 1, 2005; 81(1): 304S - 312S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Engler, M. M. Engler, C. Y. Chen, M. J. Malloy, A. Browne, E. Y. Chiu, H.-K. Kwak, P. Milbury, S. M. Paul, J. Blumberg, et al. Flavonoid-Rich Dark Chocolate Improves Endothelial Function and Increases Plasma Epicatechin Concentrations in Healthy Adults J. Am. Coll. Nutr., June 1, 2004; 23(3): 197 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Mennen, D. Sapinho, A. de Bree, N. Arnault, S. Bertrais, P. Galan, and S. Hercberg Consumption of Foods Rich in Flavonoids Is Related to a Decreased Cardiovascular Risk in Apparently Healthy French Women J. Nutr., April 1, 2004; 134(4): 923 - 926. [Abstract] [Full Text] [PDF] |
||||